Comcast Currently Down Eight Consecutive Days, on Track for Longest Losing Streak Since December 2018 — Data Talk
Comcast Corporation Class A (CMCSA) is currently at $39.66, down $0.49 or 1.22%
--Would be lowest close since Oct. 27, 2023, when it closed at $39.64
--Currently down eight consecutive days; down 8.51% over this period
--Longest losing streak since Dec. 24, 2018, when it fell for eight straight trading days
--Worst eight day stretch since the eight days ending Feb. 13, 2024, when it fell 10.44%
--Down 8.51% month-to-date
--Down 9.56% year-to-date
--Down 35.77% from its all-time closing high of $61.75 on Sept. 2, 2021
--Up 5.37% from 52 weeks ago (April 12, 2023), when it closed at $37.64
--Down 15.83% from its 52-week closing high of $47.12 on Aug. 30, 2023
--Up 8.6% from its 52-week closing low of $36.52 on April 26, 2023
--Traded as low as $39.38; lowest intraday level since Oct. 27, 2023, when it hit $37.92
--Down 1.92% at today's intraday low; largest intraday percent decrease since April 1, 2024, when it fell as much as 3.46%
All data as of 10:58:26 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 10, 2024 11:15 ET (15:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters